Nav: Home

Save the date; Less than 6 months to The International Liver CongressTM 2017

November 30, 2016

We are delighted to invite you to attend the 52nd Annual Congress of EASL, The European Association for the Study of the Liver. The International Liver Congress™ (ILC) 2017 will be held 19-23 April, at the RAI Congress Centre, Amsterdam, The Netherlands.

With less than six months to go, media registration for The International Liver CongressTM 2017 is now open!

Media registration is free of charge for all valid press card holders or via provision of formal journalist credentials. To obtain your personalised press registration code, please email the ILC Press Office Team (ilcpressoffice@ruderfinn.co.uk). Once you have this code, you will be able to register online.

The International Liver CongressTM is a multi-disciplinary scientific event which attracts over 10,000 delegates from around the world every year. Our aim is to showcase the latest advances in hepatology and unveil a wide variety of new, innovative data to improve the management of liver disease.
-end-
Ground-breaking data will be presented at three official press conferences, there will be an on-site press centre and private rooms available for conducting interviews with key speakers and EASL Governing Board members. More information on the press office and media activities at ILC 2017 can be found on the ILC 2017 website .

The ILC Press Office Team is available to answer any questions you may have and can be contacted at: ILCpressoffice@ruderfinn.co.uk. Further information on media registration can be found here: http://ilc-congress.eu/media-registration/.

We look forward to welcoming you in Amsterdam!

European Association for the Study of the Liver

Related Liver Articles:

Immune cell identity crisis: What makes a liver macrophage a liver macrophage?
UC San Diego researchers investigated how a type of immune cell called a macrophage becomes specialized to the liver.
Liver transplants could be redundant with discovery of new liver cell
Researchers at King's College London have used single cell RNA sequencing to identify a type of cell that may be able to regenerate liver tissue, treating liver failure without the need for transplants.
How viable is your liver after you die?
In a paper to be published in a forthcoming issue of TECHNOLOGY, a group of researchers from Harvard Medical School have done a study on the viability of donated livers and its correlation with donor demographics.
Blocking platelets: A possible option to prevent fatty liver disease and liver cancer
Blood platelets which interact with liver cells and immune cells play a major role in the development of fatty liver disease, non-alcoholic fatty liver inflammation and liver cancer, scientists from the German Cancer Research Center (DKFZ) in Heidelberg and from Zurich University and University Hospital have now shown in a publication.
Micro-control of liver metabolism
A new discovery has shed light on small RNAs called microRNAs in the liver that regulate fat and glucose metabolism.
Liver transplants double for alcohol-related liver disease
The proportion of US liver transplants for alcohol-associated liver disease (ALD) has doubled in the last 15 years, in part due to broader acceptance of waiving the mandated period of sobriety before transplants for this population, according to a study by researchers at UC San Francisco, which showed ongoing regional geographic variations in liver transplant rates for ALD patients, whose long-term survival rate is slightly lower than other liver transplant patients.
Liver transplant for alcohol-related liver disease in US
The proportion of liver transplants in the United States for alcohol-associated liver disease increased between 2002 and 2016, with much of the increase associated with a decrease in liver transplant for hepatitis C virus infection because of antiviral therapy.
Real-time detection of cholesterol in liver-on-chip cultures of human liver cells
In a paper to be published in the September/December 2019 issue of TECHNOLOGY, a team of researchers from the IIT, Chicago, has developed a novel microfluidic device for measuring in real-time the cholesterol secreted from liver tissue-chip containing human hepatocytes.
New genetic cause of liver fat uncovered
New research has uncovered genetic variations that may contribute to the development of non-alcoholic fatty liver disease (NAFLD), the leading cause of liver disease.
Sleeping beauty helps identify genes involved in a fatty liver-associated liver cancer
Hepatocellular carcinoma, a deadly form of liver cancer, is increasingly being linked to non-alcoholic fatty liver disease; however, the underlying genetic mechanism of disease progression had remained unknown.
More Liver News and Liver Current Events

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Rethinking Anger
Anger is universal and complex: it can be quiet, festering, justified, vengeful, and destructive. This hour, TED speakers explore the many sides of anger, why we need it, and who's allowed to feel it. Guests include psychologists Ryan Martin and Russell Kolts, writer Soraya Chemaly, former talk radio host Lisa Fritsch, and business professor Dan Moshavi.
Now Playing: Science for the People

#538 Nobels and Astrophysics
This week we start with this year's physics Nobel Prize awarded to Jim Peebles, Michel Mayor, and Didier Queloz and finish with a discussion of the Nobel Prizes as a way to award and highlight important science. Are they still relevant? When science breakthroughs are built on the backs of hundreds -- and sometimes thousands -- of people's hard work, how do you pick just three to highlight? Join host Rachelle Saunders and astrophysicist, author, and science communicator Ethan Siegel for their chat about astrophysics and Nobel Prizes.